Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages

Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages

Osteosarcoma is the most prevalent bone cancer, and chemotherapy is still an indispensable treatment in its clinical practice. Cisplatin (CDDP) has become the most commonly used agent for osteosarcoma, although the outcomes of CDDP chemotherapy remain unsatisfactory because of frequent resistance. H...

Full description

Bibliographic Details
Main Authors: Jincheng Wang, Jialu Jin, Ting Chen, Qian Zhou
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Molecules
Subjects:
osteosarcoma
CDDP
curcumol
chemoresistance
M2-like macrophages
Online Access:https://www.mdpi.com/1420-3049/27/14/4345

Internet

https://www.mdpi.com/1420-3049/27/14/4345

Similar Items